NANEXA — Nanexa AB Share News
0.000.00%
Last trade - 00:00- SEK676.32m
- SEK604.28m
- SEK36.15m
Brief: Nanexa July-Sept EBIT Loss Widens To SEK 11.9 Mln
Brief: Nanexa Signs Evaluation Agreement With Pharma Company
Brief: Nanexa, Vitrivax Reach Agreement In Principle
Brief: Nanexa Develops Long-Acting Formulation
Brief: Nanexa Signs Evaluation Deal With Pharmaceutical Company
Brief: Nanexa Q2 EBIT Loss Widens To SEK 15.9 Mln
Brief: Nanexa Q2 EBIT Loss Widens To SEK 15.9 Million
Brief: Nanexa Receives Extended GMP-Certificate For New Pilot Plant
Brief: Nanexa Extends Collaboration Agreement With Applied Materials
Brief: European Patent Office Grants Nanexa’s Pharmashell® Patent
Brief: Nanexa Q1 EBIT Loss Widens To SEK 12.3 Mln
Brief: Positive Development In Nanexa’s Patent Litigation Case
Brief: Nanexa Q4 EBIT Loss Widens To SEK 13.0 Million
Brief: Nanexa Granted Patent In U.S
Brief: Nanexa Q3 EBIT Loss Widens To SEK 7.9 Mln
Brief: Nanexa Signs Additional Evaluation Agreement
Brief: Nanexa Receives Orders For Coating Of Sensors
Brief: Nanexa's PharmaShell To Be Granted Patent In Europe
Brief: Nanexa Raises Around SEK 126.7 Mln In Fully Subscribed Rights Issue